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A global perspective on smoking during pregnancy
Smoking during pregnancy is associated with pregnancy 
complications, such as pre-eclampsia, placenta praevia, 
and placental abruption, and with poor fetal outcomes 
such as low birthweight, premature birth, stillbirth, 
sudden infant death syndrome, and high overall 
perinatal mortality.1,2 Yet comprehensive population 
data on the prevalence of smoking during pregnancy 
at the country, regional, or global level are limited. The 
Global Tobacco Surveillance System3 provides data on 
the prevalence of tobacco use by adults and young 
people but does not include data on pregnant women.
In The Lancet Global Health, Shannon Lange and 
colleagues4 report the results of a systematic review and 
meta-analysis of the scientific literature from the past 
30 years to estimate the prevalence of smoking during 
pregnancy by country, WHO region, and globally. Where 
possible, country-specific reports were combined to 
provide precise estimates of prevalence. For countries 
with little or no data, multilevel modelling was used to 
predict prevalence. The global prevalence of smoking 
during pregnancy was estimated to be 1·7% (95% CI 
0·0–4·5), with wide variations between countries and 
regions. The prevalence was highest in the European 
Region and in the Region of the Americas. Smoking 
during pregnancy was a highly prevalent behaviour 
worldwide, and the investigators call for increased 
efforts to prevent and stop smoking during pregnancy.
Lange and colleagues made an extensive effort to 
review the relevant scientific literature. They included 
predictions of global and regional estimates of the 
frequency and quantity of cigarette use and projected 
future prevalence trends. Although their estimates 
provide a much-needed statement about smoking 
during pregnancy worldwide, there is also a need 
for caution when interpreting their estimates. Only 
43 countries had two or more prevalence reports, 
and estimates were projected for the remaining 
131 countries. Another limitation was the exclusion 
of smokeless tobacco use. Concern is growing over 
the frequent use of smokeless tobacco by women, 
particularly in Asia and Africa,5 and over its use during 
pregnancy6 given its potential to cause poor birth 
outcomes.7 Despite these limitations, the data offer 
a useful basis to advocate for policies that address 
smoking in pregnancy and for future studies to gather 
nationally representative data in countries where 
prevalence is unknown.
The prevalence data are consistent with a recent 
analysis based on Demographic and Health Survey data 
from 54 countries,6 in which the global pooled estimate 
of tobacco smoking prevalence during pregnancy was 
1·3% (95% CI 0·9–1·8). However, although this analysis 
included a higher number of reporting countries than 
in the study by Lange and colleagues, it was restricted to 
low-income and middle-income countries. Nevertheless, 
the two datasets point to an important asymmetry 
between low-income and middle-income countries 
and high-income countries. Although the prevalence 
of smoking during pregnancy is lower in Africa and Asia 
than in Europe and the Americas, the proportional ratio 
of women who smoke during pregnancy and women who 
smoke in general was relatively higher in Africa and Asia. 
This could indicate that fewer women quit smoking when 
becoming pregnant in African and Asia than in Europe 
and the Americas, suggesting a general lack of awareness 
of tobacco-related harms during pregnancy and the 
reluctance of health-care staff in antenatal clinics to ask 
about tobacco use and advise on smoking cessation.
In recent years, the tobacco industry has been targeting 
young women through marketing campaigns, particularly 
in many low-income and middle-income countries. In 
some countries, smoking has become more common in 
young girls.8 Effective media campaigns, including the 
use of social media, are needed to counter this trend and 
raise awareness in young women about the harms of 
tobacco use during pregnancy. Antenatal services also 
need to be primed to enquire about tobacco use status 
and advise on quitting, using a non-judgmental approach. 
Opt-out cessation services or routine use of carbon 
monoxide monitors to assess smoking status could 
increase the uptake of smoking cessation interventions 
and encourage more pregnant women to quit smoking. 
The clinical effectiveness, cost-effectiveness, feasibility, 
and acceptability of these approaches need further 
investigation.9,10 Additionally, a substantial number of 
pregnant women are exposed to second-hand smoke, 
especially in countries with high smoking prevalence 
and poorly established smoke-free norms.11 Efforts to 
reduce tobacco use during pregnancy should also address 
this exposure to second-hand smoke. The prevalence 
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of smokeless tobacco use during pregnancy should be 
explored in future studies. There is a need for surveillance 
systems that capture tobacco use during pregnancy. 
National surveys of pregnant women and routine data 
collected within maternal and child health services should 
include a minimal set of tobacco use questions to provide 
regular and accurate data on tobacco use.
In conclusion, Lange and colleagues make an 
important contribution to the scientific literature and 
a strong case for action to address smoking during 
pregnancy. However, there are still glaring gaps in 
research, policy, and practice on tobacco use and 
exposure surveillance. Effective ways of identifying 
smokers, increasing uptake of smoking cessation 
interventions, and improving quit rates in pregnant 
women who smoke are urgently needed.
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